Our SHE Goals and Performance

According to the principles of a sustainable development Roche is striving for a continuous improvement also in the area of safety, security, health and environmental protection. This can be achieved by changing behaviour, by adapting equipment to the most recent standards or developing new innovative processes. However, a sustainable effect can only be obtained within a longer time frame.

Roche wants to further promote this trend of continuous improvement in the various areas of SHE and achieve progress where ever it is possible and economically viable. In a series of workshops, aimed at the Roche Group, as well as discussions with internal and external experts, mid-term targets have been set for the period 2020–2025.

Ensure uninterrupted delivery of key products and services at a minimum acceptable level following a disruptive incident.
K19 directive compliance rate.
Ensure legal SHE compliance.
Implement audit recommendations.
Roche only works with suitable business partners.
Commercial sites. ≥90%
Manufacturing, Distribution and R&D sites. 100%
All Roche sites and affiliates, when combined, show an average compliance rate of ≥90%.
≥98% of sites have a legal SHE compliance process in place and a signed Compliance Statement.
≥90% implementation rate after 3 years.
≥98% of K15 business partners are assessed for and compliant with Group SHE Directive K15, Annex 1. Goal to be revised. Proposal is in discussion.
Base Year / Value
2020 / 87%
2020 / 81%
2021 / 87.6%
2020 / Processes are being developed.
Every year starting 2023
2020 / Processes are being developed.
Target Year / Value
2025 / ≥90%
2025 / 100%
2025 / ≥90%
2025 / ≥98%
2025 / ≥90%
2025 / ≥98%
Status 2022
87.1% (117 sites completed the K19 gap analysis in RARI)
16% of Sites reported accordingly.
Approx 80%
Target 2023
The process is being developed. No specific target for 2023. The next measurement will be at the end of 2023.
Processes are being developed.
Eco-Efficiency: Minimise total environmental impact. (million points/employee)
Eco-Efficiency: Minimise environmental impact. Operations (million points/employee))
Eco-Efficiency: Minimise environmental impact. Products (Product Stewardship Score)
Sites2 to develop a roadmap towards zero scope 1 & 2 GHG emissions by 2050.
Increase sustainable electricity
Reduce scope 3 GHG emissions [t CO2/employee]
Reduce scope 1 & 2 energy consumption [Fossil fuel equivalent GJ/employee]
Reduce GHG emissions from business flights [t CO2/employee]
Reduce scope 1 & 2 GHG emissions [t CO2/employee]
Phase-out halogenated hydrocarbons for refrigeration [tons absolute]
Reduce general waste (excluding construction waste) [kg/employee]
General waste to be recycled (excluding construction waste)
Reduce plastic waste (separated fraction in general waste) [tons absolute]
Reduce nutrient discharges to receiving waters [tons absolute]
Reduce water consumption [water risk weighted consumption per employee]
Stop the use of SVHC5
+25% by 2025 +50% by 2029
All sites covering 85% of Roche’s scope 1&2 emissions.
Ro3: –25%
GV4: –25%
Roche Group: –100%
Nitrogen: –5%
Phosphorus –90%
Any SVHC should be phased out of all products and processes at every Roche affiliate worldwide.
Note: More and more substances are regularly declared SVHC by the European Chemicals Agency.
Base Year / Value
2019 / 7.43
20191 / 7.43
2021 / 29.9%
2020 / 67.8%
20191/ 7.28
2020 / 140.33
20191/ 2.28
2020 / 4.30
2020 / 5.456
2022 / 82.5
2020 / 95.56
2020 / 310
2020 / 65
2020 / 3,365
2020 / 39.021
2020 / 29.648
2020 / 75.92
per SVHC: the date of listing as a SVHC.
Target Year / Value
2029 / 3.71
2025 / 4.75
2025 / 37.3% 2029 / 44.8%
2025 / 100%
2025 / 5.97
2025 / 126.30
2025 / 1.87
2025 / 2.58
2025 / 4.092
2027 / 61.88
2030 / 0
2025 / 279
2025 / 80
2025 / 3,028
2025 / 37.07
2025 / 2.96
2025 / 64.54
per SVHC: 10 years after listing.
Status 2022
Sites2 have developed a roadmap.
50 SVHCs used in Roche reached their phase-out timeline.
Target 2023
Under review. No target set for 2023.
No target set
No target set
No target set.
No target set.
No target set.
No target set9
No target set9
Reduce Roche Accident Rate (RAR) [lost working days per employee]
Reduce number of vehicle collisions [collisions / million km]
Improve the maturity of health risk assessments and management, in particular for psychosocial risks.
Offer healthy workplaces11
Increase the sites’ mean score in each part of the self-assessment tool in Directive K1 Annex 58.
Increase in Health & Wellbeing scores in the Global Employee Opinion Survey (GEOS).
Base Year / Value
-7/ 0.053
20191 / 7.36

Commitment: 7.4 Approach: 36.2 Culture: 11.8

Environment and Culture: 75 Health and Wellbeing: 72 Impact on Health: 66
Target Year / Value
2025 / <0.056
2025 / 6.62

Commitment: >9.5 (<5% gap from the maximum score)
Approach: ≥56 (≤25% gap from the maximum score)
Culture: ≥13.5 (≤10% gap from the maximum score)
Status 2022
0.044 (5-year average)

Commitment: 8.0 Approach: 47.8 Culture: 12.3
No GEOS survey in 2022.
Target 2023
No target set.

Commitment: 9 Approach: 50 Culture: 13
No goals will be set.
Improve SHE Education throughout Roche
Every new employee (including managers) finishes approximately 45 minutes of basic SHE Training.
Every employee (including managers) finishes a global, approximately 45 minutes training on a specific SHE topic per year.
90% of all sites have a SHE education matrix for all employees (including managers) and 90% of the training is done accordingly.
Base Year / Value
2020 / -
2020 / -
Target Year / Value
2025 / Every new employee
2025 / Every employee
Status 2022
Training is in development
Training/Awareness was released in 202110
Processes are being developed.
Target 2023
Every new employee
Every employee
Processes are being developed.
  1. The 2020 value was heavily influenced by the SARS-CoV-2 pandemic and therefore the data from 2019 is used as the baseline.

  2. Sites covering 85% of the Roche Group scope 1 & 2 GHG emissions

  3. Ro = Roche Legacy Sites

  4. GV = Genentech/Ventana

  5. SVHC = Substances of Very High Concern

  6. 5-year average (2021–2025)

  7. The baseline was determined by taking the 3-year average over 2016–2018.

  8. The self-assessment tool for K1 Annex 5 consists of three parts with the following maximum scores:
    • Commitment = 10 (=100%)
    • Approach = 75 (=100%)
    • Culture = 15 (=100%)

  9. Due to the way nitrogen and phosphorus are used in biomanufacturing the goal is expected to be achieved via material substitution and thus the goal is expected to be accomplished in a single event. Annual reduction targets cannot be set.

  10. Why is SHE at Roche so important?

  11. Health & Wellbeing scores were created in GEOS that can be monitored and acted upon until 2025.

In addition to the 5-year goals for 2015 - 2020, which are still ongoing, we have established the next set of 5-year goals for the years 2020 - 2025, including a 10-year ambition (2029) for a 50% reduction of our total environmental impact (eco-balance for operations and product stewardship score for products) and a goal to achieve real zero greenhouse gas emissions from scope 1 & 2 (own operations and purchased energies) by 2050. For the detailed goals please see: SHE Goals 2020 - 2025 for the Roche Group

Monitoring performance

Roche is committed to sustainable development. Our goals reflect that commitment as we strive for continuous improvement wherever possible and economically viable. Careful use of resources with minimal environmental impact is an important element in sustainable development. Reflecting its commitment to sustainability, Roche is continuously endeavouring to reduce its consumption of materials and energy and to cut the quantities of waste and emissions it generates. We are making steady progress toward our goals, however, sustainable benefits can only be realised over a longer time frame.

We evaluate environmental performance by annually collecting, aggregating and reporting relevant data from individual Roche sites. We aim for 95% coverage of each performance indicator. Our key performance indicators include:

  • energy consumption and use of sustainable energy

  • total eco-balance and toxicity of our wastewater

  • emissions into water and air and waste disposal

  • training and education of employees

  • audit findings

We are committed to benchmarking our performance against the industry and best practice; this includes transparent reporting.

We conduct regular internal audits at all our sites e.g. chemical, bio-tech, pharmaceutical and diagnostics manufacturing. The audit frequency for facilities is determined by risk potential, strategic importance, past performance and other site-specific circumstances. Plant management and local SHE officers conduct more frequent spot checks and inspections to assess compliance with SHE standards.

We expect contract manufacturers, suppliers and service providers to meet the same SHE standards as we do. To ensure compliance with these standards, we, or third-party auditors retained by us, periodically inspect the operations of our most critical suppliers, such as manufacturers of chemical intermediates, finished products or exclusive equipment parts and waste vendors.

Read more on our supplier audits

We analyse all audit findings to identify areas requiring improvement. Specific findings may also lead to the development of new standards or guidelines. In the event of unsatisfactory performance by a supplier, we issue recommendations for improvement, or we may terminate a contract or refuse to award a new contract to that supplier.

When determining environmental key performance indicators, we consider material internal factors, Group strategies and goals, and external factors, such as regulations and laws, reporting conventions and stakeholder expectations. We also select those indicators that best reflect our impacts on the environment.

Roche follows the guidelines of the Global Reporting Initiative (GRI) and European Chemical Industry Council (CEFIC) for the selection of indicators data collection and reporting. To ensure the reliability of our sustainability reporting, our SHE performance figures have undergone an external verification since 1998.

Important (material) issues

In Group SHE, we are constantly aware of SHE material issues. We regularly gather information concerning SHE related risks and opportunities from Roche affiliates as well as consult with and listen to our stakeholder groups. In a further step, we match the stakeholder issues with our internal strategic priorities and risks framework to produce our materiality matrix.

Using this method we have been able to identify the material topics which stand out as areas of interest to Group SHE and its stakeholders. With a clear and defined process, Roche creates progress through target setting. By knowing our material issues and what we want to achieve we are able to set targets and initiate action plans. The new goals are feasible but challenging and are in the areas of people, environment and business.

Within the field of social development, we focus on people’s health, integrity and wellbeing. Human rights and education / development form an important part of this material sustainable issue and are part of corporate responsibility.

The following key performance indicators are monitored and reported:

  • occupational accidents;

  • occupational illnesses;

  • SHE education of our employees.

Environmental protection and the conservation of resources are very material to a sustainable future and form an important part of Roche policies.

The following key performance indicators are monitored and reported:

  • energy consumption and use of sustainable energy;

  • use of resources

  • emissions into air (including greenhouse gases), water and soil

  • waste generation and disposal

  • total eco-balance (a summary parameter for the above elements).

Economic development and governance encompass material issues such as company assets and functional efficiency as well as business continuity and the cost of safety, security, health, and environmental protection. Compliance with external and internal regulations is equally important within this area of company sustainability.

The following key performance indicators are monitored and reported:

  • compliance with all SHE laws and regulations;

  • reduction of the total SHE risk load;

  • the closing of gaps identified during our internal SHE audits;

  • improvement of the SHE performance of our suppliers and service providers;

  • investments in and cost of SHE facilities and processes.

Performance Indicators

A company's SHE-performance is assessed by means of indicators which are defined by international organisations, professional and industry associations and other interest groups. For the environmental dimension these indicators are referring to impacts on living and non living natural systems, land, air and water. Safety and health indicators describe occupational impacts on our employees such as accidents and diseases.

Performance information is provided in terms of both absolute figures and normalised measures. Absolute figures provide a sense of scale or magnitude of impacts which allows the user to consider performance in the context of larger systems. Normalised figures illustrate the organisation’s efficiency and support comparison between organisations of different sizes.

Amendments of reporting guidelines and the constant state of flux in Roche's business environment (purchases or sales of business areas, changes of product ranges, etc.) mean that the values for individual parameters are not exactly comparable year on year. We nevertheless demonstrate continuous improvement in our SHE performance over longer times.

Our goals


Discover more